Head-to-head · Cost-Efficiency Index
Curex vs KERNX Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Curex
People who want a low-cost first month, an oral option, and a verified pharmacy nationwide, and don't need a dose-by-dose price table before signing up.
Visit CurexKERNX Health
Shoppers comparing the real cost at their prescribed dose rather than the advertised entry price.
Visit KERNX HealthThe verdict
Curex takes it, leading the Cost-Efficiency Index 81 to 79. A discounted first month ($49-$149) steps up to a 'starting at $199' ongoing rate — real, but not the flat, fully-disclosed price the headline implies, and California loses the injectable route entirely. KERNX Health still earns a C — Shoppers comparing the real cost at their prescribed dose rather than the advertised entry price.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Curex.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Curex | KERNX Health |
|---|---|---|
| Cost-Efficiency Index | 81/100 | 79/100 |
| Semaglutide / mo | $199/mo Starting (first month $49) | $129/mo (compounded) |
| Tirzepatide / mo | $199/mo Starting (first month $149) | $229/mo (compounded) |
| Semaglutide / yr (modeled) | $2,388 | $1,548 |
| Tirzepatide / yr (modeled) | $2,388 | $2,748 |
| Coverage | All 50 states (California: oral tablet only, no injectable) | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #29 | #36 |
Curex
81/100Where the value is
- Discounted first month well below the ongoing rate — $49 for semaglutide, $149 for tirzepatide
- Nationwide enrollment (all 50 states) plus an oral/sublingual route as an alternative to injections
- 365-day money-back guarantee and a full refund if never prescribed
The tradeoffs
- The '$199/mo' figure is labeled 'Starting,' not flat — no dose-by-dose price table is published, so the real cost at a higher maintenance dose is unverified
- California residents cannot get the injectable route at all — oral tablets only, despite the 'all 50 states' enrollment claim
Regulatory note: the FDA issued a warning letter to Curex in September 2025. We still list and link to Curex; you should know the letter is on the public record before you decide.
KERNX Health
79/100Where the value is
- Names individual licensed providers (MDs and NPs) with credentials rather than a vague 'our doctors' claim
- Serves all 50 states through a licensed physician network
- Publishes the full dose ladder for both molecules — semaglutide to $199, tirzepatide to $329 — so the cost at a higher dose is knowable before starting
The tradeoffs
- A separate one-time consultation fee of $25 to $60 applies on top of the first month's medication cost
- No specific compounding pharmacy partner is named anywhere public
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.